Creatine treatment promotes differentiation of GABA‐ergic neuronal precursors in cultured fetal rat spinal cord
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Creatine is a substrate of cytosolic and mitochondrial creatine kinases. Its supplementation augments cellular levels of creatine and phosphocreatine, the rate of ATP resynthesis, and improves the function of the creatine kinase energy shuttle. High cytoplasmatic total creatine levels have been reported to be neuroprotective by inhibiting apoptosis. In addition, creatine has direct antioxidant effects, which may be of importance in amyotrophic lateral sclerosis. In the present study, we investigated the effects of creatine [5 mM] on survival and differentiation of cultured GABA‐immunoreactive (‐ir) and choline acetyltransferase (ChAT)‐ir rat spinal cord neurons. Furthermore, we addressed the neuroprotective potential of creatine supplementation against 3‐nitropropionic acid (3‐NP) induced toxicity. General cell survival and total neuronal cell density were not altered by chronic creatine treatment. We found, however, after chronic creatine and short‐term creatine exposure a significantly higher density of GABA‐ir neurons hinting to a differentiation‐inducing mechanism of creatine. This notion is further supported by a significant higher content of GAD after creatine exposure. Creatine supplementation also exerted a partial, but significant neuroprotection for GABA‐ir neurons against 3‐NP induced toxicity. Interestingly, chronic creatine treatment did not alter cell density of ChAT‐ir neurons but promoted their morphologic differentiation. Cell soma size and number of primary neurites per neuron were increased significantly after creatine supplementation. Taken together, creatine supplementation promoted the differentiation or the survival of GABAergic neurons and resulted in partial neuroprotection against 3‐NP induced toxicity. The data suggest that creatine may play a critical role during development of spinal cord neurons. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CNS energy metabolism as related to function
Ames, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00038-2 · Cited by 663
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Direct antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448 · cited 2×
“, 2004), where the direct antioxidant properties of creatine may be implicated (Lawler et al., 2002).”
BackgroundBrewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Self-citation‘Hot spots’ of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus
Kaldis, P., Hemmer, W., Zanolla, E., Holtzman, D., & Wallimann, T. (2009) · Developmental Neuroscience · doi:10.1159/000111452 · Cited by 99 · cited 1×
“Although we detected that all neurons colocalized with BB-CK and uMt-CK in our spinal cord cultures, previous reports have shown that CKs are also present in oligodendrocytes and astrocytes (Molloy et al., 1992; Kaldis et al., 1996; Andres et al., 2005b).”
BackgroundSelf-citationRabchevsky, A. G., Sullivan, P. G., Fugaccia, I., & Scheff, S. W. (2003) · Journal of Neurotrauma · doi:10.1089/089771503322144572 · Cited by 70 · cited 2×
“Creatine supplementation has also been shown to have protective effect after spinal cord injury (Hausmann et al., 2002; Rabchevsky et al., 2003) and in transgenic mouse-model of amyotrophic lateral sclerosis (ALS) (Klivenyi et al., 1999; 2004; Zhang et al., 2003; Dupuis et al., 2004), where the…”
BackgroundProtective effects of oral creatine supplementation on spinal cord injury in rats
Hausmann, O., Fouad, K., Wallimann, T., & Schwab, M. (2002) · Spinal Cord · doi:10.1038/sj.sc.3101330 · Cited by 61 · cited 2×
“Creatine supplementation has also been shown to have protective effect after spinal cord injury (Hausmann et al., 2002; Rabchevsky et al., 2003) and in transgenic mouse-model of amyotrophic lateral sclerosis (ALS) (Klivenyi et al., 1999; 2004; Zhang et al., 2003; Dupuis et al., 2004), where the…”
BackgroundSelf-citation
Cited by
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P. (2016) · Amino Acids · doi:10.1007/s00726-016-2173-8 · Cited by 60
A potential role for creatine in drug abuse?
D’Anci, K. E., Allen, P. J., & Kanarek, R. B. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8176-2 · Cited by 9
Metadata
- Authors
- Ducray, A. D., Schläppi, J., Qualls, R., Andres, R. H., Seiler, R. W., Schlattner, U., Wallimann, T., & Widmer, H. R.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-05-24
- Volume
- 85
- Issue
- 9
- Pages
- 1863-1875
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2033654927
- Cited by
- 31
- References
- 7
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.